These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2665175)

  • 21. Laboratory diagnosis of von Willebrand disorder. Current practice in the southern hemisphere.
    Favaloro EJ; Bonar R; Sioufi J; Hertzberg M; Street A; Lloyd J; Marsden K;
    Am J Clin Pathol; 2003 Jun; 119(6):882-93. PubMed ID: 12817437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
    Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H
    Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentrates.
    Favaloro EJ; Bukuya M; Martinelli T; Tzouroutis J; Duncan E; Welldon K; Collecutt M; Aumann H; Thom J; Gilmore G
    Thromb Haemost; 2002 Mar; 87(3):466-76. PubMed ID: 11916080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis.
    Schmitz-Huebner U; Thompson SG; Balleisen L; Fechtrup C; Grosse-Heitmeyer W; Kirchhof B; Most E; Müller US; Seiffert C; Seiffert D
    Br Heart J; 1988 Mar; 59(3):287-91. PubMed ID: 3258521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inter-laboratory comparison of HCV-RNA assay results: implications for multi-centre research.
    Pembrey L; Newell ML; Tovo PA; van Drimmelen H; Quinti I; Furlini G; Galli S; Meliconi MG; Burns S; Hallam N; Sönnerborg A; Cilla G; Serrano E; Laccetti P; Portella G; Polywka S; Icardi G; Bruzzone B; Balbo L; Alfarano A;
    J Med Virol; 2003 Feb; 69(2):195-201. PubMed ID: 12683407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term prognostic value of lipid measurements in patients with angina pectoris. The ECAT Angina Pectoris Study Group: European Concerted Action on Thrombosis and Disabilities.
    Bolibar I; von Eckardstein A; Assmann G; Thompson S;
    Thromb Haemost; 2000 Dec; 84(6):955-60. PubMed ID: 11154140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The von Willebrand factor in myocardial infarction and unstable angina: a kinetic study.
    Margulis T; David M; Maor N; Soff GA; Grenadier E; Palant A; Aghai E
    Thromb Haemost; 1986 Jun; 55(3):366-8. PubMed ID: 3092393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinogen, factor VIII related antigen, antithrombin III and alpha 2-antiplasmin in peripheral arterial disease.
    Christe M; Delley A; Marbet GA; Biland L; Duckert F
    Thromb Haemost; 1984 Dec; 52(3):240-2. PubMed ID: 6442467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory diagnosis of von Willebrand's disorder: quality and diagnostic improvements driven by peer review in a multilaboratory test process.
    Favaloro EJ; Bonar R; Kershaw G; Sioufi J; Hertzberg M; Street A; Lloyd J; Marsden K;
    Haemophilia; 2004 May; 10(3):232-42. PubMed ID: 15086320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification.
    Favaloro EJ; Bonar R; Marsden K
    Clin Lab Sci; 2008; 21(3):178-83. PubMed ID: 18678140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
    Mahieu B; Jacobs N; Mahieu S; Naelaerts K; Vertessen F; Weyler J; Jacquemyn Y; Van der Planken M
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of the hemostasis in unstable angina pectoris].
    Lisowski P; Małyszko J; Lisowska A; Czech B; Myśliwiec M; Jackowski R; Hirnle T
    Pol Merkur Lekarski; 2004 May; 16(95):468-71. PubMed ID: 15518429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM; Goy C; Budek I; Seitz R
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study.
    Yarnell J; McCrum E; Rumley A; Patterson C; Salomaa V; Lowe G; Evans A
    Eur Heart J; 2005 Feb; 26(4):332-42; discussion 317-8. PubMed ID: 15618045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seminal Factor VIII and von Willebrand Factor: a possible role of the conventional clotting system in human semen?
    Lwaleed BA; Greenfield R; Royle E; Birch B; Cooper AJ
    Int J Androl; 2005 Feb; 28(1):31-8. PubMed ID: 15679619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External quality assessment scheme for hemostasis in India.
    Mammen J; Nair SC; Srivastava A
    Semin Thromb Hemost; 2007 Apr; 33(3):265-72. PubMed ID: 17427061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.